| Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376) |
|---|
| 07/11/2006 | US7074970 Process for producing vinyl ether compounds |
| 07/11/2006 | US7074823 Zinc complex containing spiro(phthalan-1,9'-xanthene) ring; measuring intensity of fluorescence |
| 07/11/2006 | US7074801 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof |
| 07/11/2006 | CA2198751C Dihydro-2,3-benzodiazepine derivatives |
| 07/11/2006 | CA2125830C Heteroaryl cinnamic acids as inhibitors of leukotriene biosynthesis |
| 07/11/2006 | CA2125824C Heteroaryl coumarins as inhibitors of leukotriene biosynthesis |
| 07/06/2006 | US20060149064 Process to prepare malayamycin derivatives |
| 07/06/2006 | US20060148890 Substituted furochromene compounds of antiinflammatory action |
| 07/06/2006 | US20060148889 2-(4-Hydroxy-2-oxo-2H-chromene-3-yl)-4H-furo[3,2-c]chromene-4-one; prophylaxis and treatment of allergies, asthma and other inflammatory diesases |
| 07/06/2006 | US20060148865 Preparation of chemical compounds |
| 07/06/2006 | US20060148724 Genipin derivatives and uses thereof |
| 07/05/2006 | EP1095042B9 Antiparasitic artemisinin derivatives (endoperoxides) |
| 07/05/2006 | CN1796388A Sesamin/episesamin compositions |
| 07/05/2006 | CN1262587C Diacetal compsn. nucleating agent contg. compsn. for polyolefin, polyolefin resin compsn. contg. diacetal compsn., process for producing resin compsn., and molded object |
| 07/04/2006 | US7070964 Epothilone compounds and methods for making the same |
| 06/29/2006 | WO2006006082A3 Multi-ring compounds for regulating gut motility, food intake, and weight gain |
| 06/29/2006 | WO2005041881A8 Taxoid-fatty acid conjugates and pharmaceutical compositions thereof |
| 06/29/2006 | US20060142598 Process for producing benzofuran derivative |
| 06/29/2006 | US20060142592 atorvastatin calcium epoxide dihydroxy (AED) is described; AED can be used as a standard or marker in determining the amount of AED in a sample |
| 06/29/2006 | US20060142584 Epothilone side components |
| 06/29/2006 | US20060142377 water-soluble carboxylic acid dimers that are thermally stable and stable toward hydrolysis, less toxicity; plasmodium protozoan parasites; human malaria and Plasmodium falciparum; leukemia, lung, colon, central nervous system, ovarian, renal, prostate, and breast cancer, melanoma |
| 06/29/2006 | US20060142370 Sumanene and method for manufacturing the same |
| 06/29/2006 | US20060142267 [6-hydroxy-2-(2-hydroxy-benzyl)-benzo [b]thiophen-3-yl]-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-methanone; [6-hydroxy-2-(2-hydroxy-benzyl)-naphthalen-1-yl]-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-methanone; 6-(2-hydroxy-benzyl)-5-{hydroxy-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-methyl}-naphthalen-2-ol |
| 06/28/2006 | EP1673089A2 Phenyl-piperazine derivatives as modulators of muscarinic receptors |
| 06/28/2006 | CN1261436C Bibenzil compound 13,13'-O-iso-propylidene riccardia D and its extraction and separation method and use |
| 06/28/2006 | CN1261435C Purifying method for obtaining high-purity pyromellitic dianhydride |
| 06/27/2006 | US7067544 a high purity epothilone from Sorangium cellulosum; anticarcinogenic, antitumor agents |
| 06/27/2006 | US7067510 5-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-5,11-dihydro-6-oxa-12-thia-dibenzo[a,f]azulen-2-ol; 13-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-7,13-dihydro-12-oxa-benzo[4,5]cyclohepta[1,2-a]naphthalen-3-ol or derivatives or salts; for alleviating symptoms of estrogen deprivation, including bone loss |
| 06/27/2006 | US7067286 Cystobacterineae host cells containing heterologous PKS genes for the synthesis of polykedtides |
| 06/22/2006 | US20060135598 citirus-based furocoumarins; for dietary supplements or medicinal foods |
| 06/22/2006 | US20060135474 Methods for the preparation, isolation and purification of epothilone B, and X-ray crystal structures of epothilone B |
| 06/22/2006 | US20060135445 Breast cancer-resistant protein inhibitor |
| 06/21/2006 | EP1671980A2 Avermectin derivatives |
| 06/21/2006 | EP1670804A2 Heterobicyclic compounds as pharmaceutically active agents |
| 06/21/2006 | EP1463504B1 Compositions comprising epothilones and their use for the treatment of the carcinoid syndrome |
| 06/21/2006 | EP0932398B1 Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of manic-depressive bipolar disorders |
| 06/21/2006 | CN1260231C 2,2-dimethylene dioxy group 1,3-propylene glycol carbonate, preparation method and application thereof |
| 06/15/2006 | US20060128975 Immunosuppressants and apoptosis for cells for anticancer agents |
| 06/15/2006 | US20060128750 Targeting chemokine receptors and interfere with the binding of the natural ligand thereto; antagonists or agonists; protecting target cells from HIV infection; treating HIV or FIV infected patients |
| 06/15/2006 | US20060128740 Tricyclic androgen receptor modulator compounds and methods |
| 06/15/2006 | US20060128685 Pyrazole derivative |
| 06/15/2006 | US20060128669 3-(4-Fluorobenzyl)-8-hydroxy-quinoline-5,7-dicarboxylic acid 7-methylester; against Human T Cell leukemia virus, Feline and Simian immunodeficiency viruses, AIDS and related clinical symptoms |
| 06/15/2006 | US20060127423 Organic compounds |
| 06/15/2006 | CA2588587A1 Cytotoxic agents comprising new taxanes |
| 06/14/2006 | EP1669384A2 Mixtures of binders which contain bicycloorthoester and/or polyorthoester groups |
| 06/14/2006 | EP1669358A1 Cytotoxic agents comprising new taxanes |
| 06/14/2006 | EP1668017A1 Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses thereof |
| 06/14/2006 | DE102004037002B4 Verfahren zur Herstellung von Dimethylaminoarglabin-Hydrochlorid A process for preparing Dimethylaminoarglabin hydrochloride |
| 06/14/2006 | CN1787994A 2,4,6-phenyl substituted cyclic ketoenols |
| 06/13/2006 | US7060840 Using a chiral, non-racemic tertiary amine catalyst,e.g., one containing a 1-azabicyclo(2.2.2)octane moiety or a 1,4-diazabicyclo(2.2.2)octane moiety. |
| 06/08/2006 | WO2006060198A1 Translation lookaside buffer (tlb) access supression for intra-page program counter relative or absolute address branch instructions |
| 06/08/2006 | WO2006060082A1 Tricyclic compounds, preparation thereof and use thereof as cholinesterase activity inhibitors |
| 06/08/2006 | US20060122260 Intermediates for aromatic polyketides as selective anticancer and antiviral agents |
| 06/08/2006 | US20060122241 Novel macrocycles for the treatment of cancer diseases |
| 06/08/2006 | US20060122126 (1S)-1,5-anhydro-1-[3-(1-benzothiene-2-ylmethyl)phenyl-D-glucitol and derivatives are Na+-glucose cotransporter inhibitors and are used to treat diabetes and related diseases such as insulin-resistance and obesity |
| 06/08/2006 | US20060122061 Arylphenyl-substituted cyclic ketoenols |
| 06/07/2006 | EP1664057A1 Polyether brevetoxin derivatives as a treatment for cystic fibrosis, mucociliary dysfunction, and pulmonary diseases |
| 06/07/2006 | EP1664056A2 Fused pentacyclic polyethers |
| 06/07/2006 | EP1664055A1 9-amino-podophyllotoxin derivatives, method for the production thereof and pharmaceutical compositions containing said derivatives |
| 06/07/2006 | EP1664033A2 9,10-alpha,alpha-oh-taxane analogs and methods for production the reof |
| 06/07/2006 | EP1663962A2 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 06/07/2006 | EP1663934A1 Alpha-hydroxy-benzeneacetic acid derivatives, and compounds having two 5-membered lactone rings fused to central cyclohexa-1,4-diene nucleus based upon the same, and uses of the compounds |
| 06/07/2006 | EP1315732B1 Radicicol and monocillin and their analogues and uses thereof |
| 06/07/2006 | CN1784244A Prodrugs cleavable by CD26 |
| 06/06/2006 | CA2327723C Bicyclic hydroxamic acid derivatives |
| 06/06/2006 | CA2258895C Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of manic-depressive bipolar disorders |
| 06/06/2006 | CA2133080C Calanolide antiviral compounds, compositions and uses thereof |
| 06/01/2006 | WO2006056850A2 Chroman compounds |
| 06/01/2006 | WO2005028481A8 Fused pentacyclic polyethers |
| 06/01/2006 | US20060116421 N-(3,5-bis-trifluoromethyl-benzyl)-1-(2-tert-butoxycarbonyl-amino-thiazol-4-yl)-3-(N-methyl, N-tetrahydro-4H-pyran-4-ylamino]-cyclopentanecarbamide; antiinflammatory agent; antiallergen; autoimmune diseases; allergic rhinitis, dermatitis, conjunctivitis, asthma, rheumatoid arthritis and atherosclerosis |
| 06/01/2006 | CA2587860A1 Chroman compounds |
| 05/31/2006 | EP1558240B1 Hypoestoxides, derivatives and agonists thereof for use in the treatment and prophylaxis of hyperlipidemia |
| 05/31/2006 | EP1345922B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1318997B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317449B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317444B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | CN1257907C Ginkgo lactone compound and its preparation and medicinal composition containing it |
| 05/31/2006 | CN1257906C Preparation process of isosorbide mononitrate |
| 05/30/2006 | US7053236 Catalytic asymmetric desymmetrization of prochiral and meso compounds |
| 05/30/2006 | US7053225 Such as 2-(t-butyldimethylsilyloxymethyl)-3,4-((dimethylmethylene)-dioxy)-5-hydroxy -tricyclo(5.2.1.02,6) deca-3,8-diene; for Diels-Alder reaction; antitumor agents |
| 05/30/2006 | US7053224 Intermediates and improved processes for the preparation of neplanocin A |
| 05/30/2006 | US7053117 Substituted 4H-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 05/30/2006 | CA2321380C 6-azauracil derivatives as thyroid receptor ligands |
| 05/26/2006 | WO2006055694A1 Novel 2h-chromene derivatives as selective estrogen receptor modulators |
| 05/26/2006 | WO2006055463A2 2-amino-3-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors |
| 05/26/2006 | CA2587669A1 Novel 2h-chromene derivatives as selective estrogen receptor modulators |
| 05/25/2006 | US20060111327 Derivatives of triptolide having a high immunosuppressive effect and high water solubility, and uses thereof |
| 05/24/2006 | EP1659125A1 Triptolide analogs for the treatment of autoimmune and inflammatory disorders |
| 05/24/2006 | EP1389619B1 Pkb-3564 substance with neovascularization inhibitory activity |
| 05/24/2006 | CN1777614A Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 05/24/2006 | CN1775781A Artemisinin extracting method |
| 05/24/2006 | CN1775780A Method for preparing 3, 4-dimethyl benzal sorbic alcohol |
| 05/23/2006 | US7048876 Photochromic compound exhibits absorption bands in two wavelength regions of 440 to 500 nm and 570 to 630 nm. |
| 05/23/2006 | CA2232141C Substituted tetracyclic tetrahydrofuran derivatives |
| 05/23/2006 | CA2215604C Process for preparation of 1,4-benzodioxane derivative |
| 05/18/2006 | US20060106234 Obtained by reacting resorcinol and phthalic anhydride in presence of potassium hydrogen sulfate and methyl benzoate ; ophthalmology, for diagnosis, in particular in medical imaging, or in the field of biotechnological applications (for example, as dye to label molecules) |
| 05/18/2006 | US20060106078 Prostamide receptor antagonists |
| 05/18/2006 | US20060106073 Process for the preparation of epothilone derivatives, new epothilone derivatives as well as new intermediate products for the process and the methods of preparing same |
| 05/18/2006 | US20060106050 Thrombin receptor antagonists |
| 05/18/2006 | US20060105966 Novel anticonvulsant derivative salts |